A Study to Evaluate the Safety and Efficacy of the PCSK9 Inhibitor AK102 in Patients With HoFH

Clinical trial NCT03933293 · COMPLETED

Trial details

NCT number: NCT03933293
Sponsor: Akeso
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Homozygous Familial Hypercholesterolemia

Start date: 2019-05-13
Primary completion: 2021-03-15
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.